IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier 34095, France.
IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier 34095, France.
Int J Pharm. 2018 Feb 15;537(1-2):94-101. doi: 10.1016/j.ijpharm.2017.12.032. Epub 2017 Dec 14.
Self-emulsifying drug delivery systems based on lipids have gained in interest in recent years due to their capacity to enhance the bioavailability of poorly water soluble drugs. Their oral intake suggests that they will be in contact with gastric and pancreatic enzymes during their passage through the gastrointestinal tract. The study of the evolution of such systems in the presence of enzymes is thus essential to develop better drug delivery vehicles. In this work, the lipolysis of two lipid based self-emulsifying drug delivery systems, Labrasol and Gelucire 44/14 by pancreatic enzymes and under conditions mimicking the gastrointestinal tract are presented. The following of the digestion is realized by Taylor dispersion analysis using fluorescent detection. A hydrophobic marker was used to tag the microdroplets. Results have shown that, Labrasol droplets decrease exponentially in size with lipolysis time, from 11.8 nm to 3.5 nm in 20 min. On the contrary, Gelucire 44/14 droplets increased sigmoïdally in size from 5.6 to 24.7 nm. Even after 120 min lipolysis, both systems maintained a solubilizing capacity of the hydrophobic marker.
近年来,基于脂质的自乳化药物传递系统由于能够提高疏水性药物的生物利用度而受到关注。它们口服后,在通过胃肠道的过程中会与胃和胰腺酶接触。因此,研究这些系统在酶存在下的演变对于开发更好的药物传递载体至关重要。在这项工作中,研究了两种基于脂质的自乳化药物传递系统(Labrasol 和 Gelucire 44/14)在模拟胃肠道条件下的胰腺酶解作用。通过使用荧光检测的泰勒分散分析来跟踪消化过程。使用疏水性标记物标记微滴。结果表明,Labrasol 液滴在脂解过程中随时间呈指数减小,在 20 分钟内从 11.8nm 减小到 3.5nm。相反,Gelucire 44/14 液滴的尺寸呈 S 形增加,从 5.6nm 增加到 24.7nm。即使在 120 分钟的脂解后,两种系统都保持了疏水性标记物的增溶能力。